Literature DB >> 6137396

Dynorphin induces partially reversible paraplegia in the rat.

A I Faden, T P Jacobs.   

Abstract

Endogenous opioids have previously been implicated in the pathophysiology of spinal cord injury, but the specific opioid(s) involved has not been determined. Here we report that dynorphin administered intrathecally causes dose-related, partially reversible, hindlimb paralysis in the unanesthetized rat. Other opioids, including mu-selective and delta-selective synthetic enkephalins or beta-endorphin, failed to induce motor dysfunction. These findings suggest that dynorphin or dynorphin-related peptides may play a role in spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137396     DOI: 10.1016/0014-2999(83)90487-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

2.  Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.

Authors:  Miriam Aceves; Eric A Bancroft; Alejandro R Aceves; Michelle A Hook
Journal:  J Neurotrauma       Date:  2016-11-04       Impact factor: 5.269

Review 3.  Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.

Authors:  Brendan M Walker; Glenn R Valdez; Jay P McLaughlin; Georgy Bakalkin
Journal:  Alcohol       Date:  2012-03-27       Impact factor: 2.405

4.  Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord.

Authors:  Kirsty Bannister; Yeon Sun Lee; Leonor Goncalves; Frank Porreca; Josephine Lai; Anthony H Dickenson
Journal:  Neuropharmacology       Date:  2014-06-14       Impact factor: 5.250

5.  Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.

Authors:  A I Faden; T P Jacobs
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

6.  Endopeptidase 24.15 inhibition and opioid antinociception.

Authors:  B Kest; M Orlowski; R J Bodnar
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Perivascular expression and potent vasoconstrictor effect of dynorphin A in cerebral arteries.

Authors:  Éva Ruisanchez; Attila Cselenyák; Rege Sugárka Papp; Tamás Németh; Krisztina Káldi; Péter Sándor; Zoltán Benyó
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

8.  Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury.

Authors:  M Aceves; B B Mathai; M A Hook
Journal:  Spinal Cord       Date:  2016-03-01       Impact factor: 2.772

9.  Randomized clinical trial comparing outcomes after fentanyl or ketamine-dexmedetomidine analgesia in thoracolumbar spinal surgery in dogs.

Authors:  Stephanie Lovell; Bradley Simon; Elizabeth C Boudreau; Joseph Mankin; Nicholas Jeffery
Journal:  J Vet Intern Med       Date:  2022-08-13       Impact factor: 3.175

10.  Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system.

Authors:  Sunil Sirohi; Georgy Bakalkin; Brendan M Walker
Journal:  Front Mol Neurosci       Date:  2012-09-27       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.